The new FERTINATAL micronized DHEA supplement from Fertility Nutraceuticals, LLC utilizes the same type of DHEA shown in studies by CHR to enhance female fertility.
New York, NY (PRWEB)fetr December 22, 2011
Fertility Nutraceuticals, LLC - a company specializing in nutritional supplements for women and female fertility enhancement - is announcing the launch of FERTINATAL™ micronized dehydroepiandrosterone (DHEA) supplement. The high-quality DHEA supplement is designed to augment female fertility.
Intrigued by anecdotal evidence received from one of their patients, physicians at New York's Center for Human Reproduction (CHR) - a leading fertility and research center - initiated research on the relationship between DHEA supplementation and enhanced female fertility. Although research on the effects of DHEA is still limited, the published results of CHR's studies are encouraging.
FERTINATAL™ was developed to offer the public exactly the same kind of DHEA utilized by CHR in the center's research studies. The product features the highest quality control standards, including a triple-step testing process with batch-testing by independent laboratories. Furthermore, FERTINATAL™ is micronized to the same particle sizes as used in those studies. The product's three-step testing process ensures that FERTINATAL™ delivers on its three promises: a plant-derived DHEA product of highest quality, micronized to appropriate sizes for good absorption.
FERTINATAL™ is the first DHEA supplement exclusively designed for women and female fertility enhancement. To improve convenience, it is uniquely packaged in individual blister sheets, each containing seven (7) rows of three (3) daily tablets, representing one week of the suggested supply of DHEA supplementation. Each box of FERTINATAL™ contains four of these blister sheets (a four-week supply). FERTINATAL™ is not intended for individuals under the age of 18, and potential side effects are described on the product's packaging.
FERTINATAL™ will become available exclusively through Fertility Nutraceuticals, LLC in January 2012.
New York, NY (PRWEB)fetr December 22, 2011
Fertility Nutraceuticals, LLC - a company specializing in nutritional supplements for women and female fertility enhancement - is announcing the launch of FERTINATAL™ micronized dehydroepiandrosterone (DHEA) supplement. The high-quality DHEA supplement is designed to augment female fertility.
Intrigued by anecdotal evidence received from one of their patients, physicians at New York's Center for Human Reproduction (CHR) - a leading fertility and research center - initiated research on the relationship between DHEA supplementation and enhanced female fertility. Although research on the effects of DHEA is still limited, the published results of CHR's studies are encouraging.
FERTINATAL™ was developed to offer the public exactly the same kind of DHEA utilized by CHR in the center's research studies. The product features the highest quality control standards, including a triple-step testing process with batch-testing by independent laboratories. Furthermore, FERTINATAL™ is micronized to the same particle sizes as used in those studies. The product's three-step testing process ensures that FERTINATAL™ delivers on its three promises: a plant-derived DHEA product of highest quality, micronized to appropriate sizes for good absorption.
FERTINATAL™ is the first DHEA supplement exclusively designed for women and female fertility enhancement. To improve convenience, it is uniquely packaged in individual blister sheets, each containing seven (7) rows of three (3) daily tablets, representing one week of the suggested supply of DHEA supplementation. Each box of FERTINATAL™ contains four of these blister sheets (a four-week supply). FERTINATAL™ is not intended for individuals under the age of 18, and potential side effects are described on the product's packaging.
FERTINATAL™ will become available exclusively through Fertility Nutraceuticals, LLC in January 2012.
